Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Cochrane on Drain Fluid Amylase and Pancreatic Leak
Cochrane; 2017 Apr 7; Davidson, Yaghoobi, et al
It is unknown whether drain fluid amylase should be used as a testing method for pancreatic leak after pancreatic resection, according to a Cochrane review of 5 studies involving 868 individuals. The optimal cut-off of drain fluid amylase for making the diagnosis of pancreatic leak is also not clear. Among the findings:
- The way that study authors confirmed that a participant had or did not have pancreatic leak was subject to error (there was no true “gold standard”).
- The studies included few participants, leading to uncertainty in the results.
- The studies were poorly performed, adding more uncertainty.
The authors concluded that well-designed studies with pre-specified index test threshold of drain fluid amylase (at 3 times more on postoperative day 5), appropriate follow-up (for at least 6 weeks to ensure that there are no pancreatic leaks), and clearly defined reference standards are needed.
Davidson T, Yaghoobi M, Davidson B, Gurusamy K. Amylase in drain fluid for the diagnosis of pancreatic leak after partial removal of the pancreas. Cochrane Database Syst Rev. 2017 Apr 7; 4:CD012009. doi:10.1002/14651858.CD012009.pub2.